Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Olov Wiklund(Translational Therapeutics (United States)), Kausik K. Ray(Imperial College London), Henry N. Ginsberg(Columbia University), Jan Albert Kuivenhoven(University Medical Center Groningen), Albert Wiegman(Amsterdam University Medical Centers), Klaus G. Parhofer(LMU Klinikum), P. Pajukanta(University of California, Los Angeles), Robert A. Hegele(Western University), Jan Borén(Göteborgs Stads), Cathérine Boileau(Hôpital Necker-Enfants Malades), Éric Bruckert(Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société), L. Masana(Universitat Rovira i Virgili), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), M. John Chapman(University of Cambridge), Steve E. Humphries(University College London), Joep C. Defesche(Academic Medical Center), Maurizio Averna(Instituto di Biofisica), Gerald F. Watts(Royal Perth Hospital), Børge G. Nordestgaard(Gentofte Hospital), Erik S.G. Stroes(Amsterdam University Medical Centers), Petri T. Kovanen(Wihuri Research Institute), Alberico L. Catapano(University of Milan), Olivier Descamps(Centre Hospitalier Universitaire de Tivoli), Anne Tybjærg‐Hansen(University of Copenhagen), G. Kees Hovingh(Novo Nordisk (Denmark)), Anton F. H. Stalenhoef(Translational Therapeutics (United States))
Cited by 1,052
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k